CureSMA to Discuss Spinraza Use, High Cost and Insurance Coverage in Webinar Set for Tuesday
Access to Spinraza (nusinersen), the first ever approved therapy for the treatment of spinal muscular atrophy (SMA), will be discussed in a webinar tomorrow.